Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha 1 Microglobulin: A Potentially Paradoxical Anti-Oxidant Agent.

Richard A Zager1

  • 1Department of Medicine, University of Washington, Seattle, WA, USA.

Advanced Techniques in Biology & Medicine
|October 17, 2017
PubMed
Summary

Alpha 1 microglobulin, an antioxidant protein, has potential clinical uses but requires further research into its in vivo effects. This review discusses physiologic considerations for its clinical application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Veverimer, a Nonabsorbed Gastrointestinal Tract HCl Binder, Decreases Renal Ammoniagenesis and Mitigates Nephrotoxic Serum Nephritis.

Kidney360·2025
Same author

RBT-1, a "preconditioning" agent, mitigates syndecan-1 shedding in patients undergoing "on pump" cardiac surgery and following experimental AKI.

Physiological reports·2025
Same author

Oxidant- induced preconditioning: A pharmacologic approach for triggering renal 'self defense'.

Physiological reports·2022
Same author

Early loss of glutathione -s- transferase (GST) activity during diverse forms of acute renal tubular injury.

Physiological reports·2022
Same author

Catalytic iron mediated renal stress responses during experimental cardiorenal syndrome 1 ("CRS-1").

Translational research : the journal of laboratory and clinical medicine·2021
Same author

Iron sucrose ('RBT-3') activates the hepatic and renal HAMP1 gene, evoking renal hepcidin loading and resistance to cisplatin nephrotoxicity.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2021

Area of Science:

  • Biochemistry
  • Physiology
  • Clinical Medicine

Background:

  • Alpha 1 microglobulin is a low molecular weight protein that binds heme.
  • It possesses antioxidant properties, suggesting potential therapeutic value.
  • Current understanding of its in vivo effects is limited.

Purpose of the Study:

  • To review the physiologic aspects of Alpha 1 microglobulin relevant to its clinical use.
  • To identify knowledge gaps concerning its in vivo functions.
  • To stimulate further research into its clinical applications.

Main Methods:

  • Literature review of existing studies on Alpha 1 microglobulin.
  • Analysis of physiologic data related to the protein's function.
  • Discussion of clinical implications based on current evidence.
Keywords:
Acute kidney failureAcute kidney injuryAlpha 1 microglobulinHemeLysosomesMyoglobinRenal ischemiaRenal oxidant stress

Related Experiment Videos

Main Results:

  • Alpha 1 microglobulin's antioxidant and heme-binding capabilities are confirmed.
  • Several key physiologic questions regarding its in vivo behavior remain unanswered.
  • Potential clinical applications exist but require more in-depth investigation.

Conclusions:

  • Further research is necessary to elucidate the in vivo roles of Alpha 1 microglobulin.
  • Understanding its physiology is crucial for developing safe and effective clinical applications.
  • Alpha 1 microglobulin represents a promising area for future biomedical research.